CoreAgeRx vs RxActivate: Pricing Transparency Compared
CoreAgeRx vs RxActivate is primarily a choice between visible flat monthly pricing and gated, clinician-matched plans. Early verdict: CoreAgeRx shows published flat monthly prices for tirzepatide and semaglutide with no membership fee, while RxActivate requires completion of an eligibility questionnaire and contact information before revealing any price or billing terms.
Start CoreAgeRx semaglutide from $79/mo
How they differ on pricing and billing
CoreAgeRx lists specific monthly prices and billing claims on its landing page: semaglutide any dose up to 1.0 mg for $79 per month and tirzepatide any dose up to 7.5 mg for $129 per month, with statements of no price hike, no membership fee and same price every month. RxActivate does not display price or billing terms before a user completes the two-minute eligibility questionnaire and provides name, email and phone number. The comparison centers on transparent published pricing versus gated pricing disclosure.
See RxActivate eligibility and pricing
CoreAgeRx vs RxActivate: clinician review and eligibility
Both providers present clinician-reviewed treatment and include state and medical-safety screening. CoreAgeRx notes a 3-minute online visit and that treatment is available only when a licensed clinician determines it is medically appropriate. RxActivate describes a two-minute eligibility questionnaire and clinician-matched GLP-1 plans with state and medical-safety screening. The timing and upfront visibility of eligibility differ: CoreAgeRx displays price alongside a short visit claim, while RxActivate requires the eligibility flow before disclosing plan details.
Start CoreAgeRx tirzepatide from $129/mo
Key differences organized by evidence
1. Price visibility and billing commitments
CoreAgeRx: publishes flat monthly pricing, emphasizes “Same Price. Every Month.” and “No Membership Fee.” It warns that other programs may increase bills after the first month. RxActivate: No price, medication fee, membership fee, shipping charge, cancellation term or billing commitment is displayed before the contact-information gate.
2. Intake length and process
CoreAgeRx: advertises a 3-minute online visit and no insurance required. RxActivate: uses a two-minute eligibility questionnaire that requests goals, history, demographics and state, then requires contact details before revealing plans and prices.
3. Medication and regulatory notes
CoreAgeRx lists specific medications and dose caps on the landing page: tirzepatide up to 7.5 mg and semaglutide up to 1.0 mg. Both sources include the regulatory note that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
4. Lead capture and disclosure tradeoffs
CoreAgeRx provides pricing and billing claims up front which may help consumers confirm cost and renewal terms before enrollment. RxActivate requires contact information before revealing price, which may be useful for clinician matching but means pricing and billing terms are not available until after lead capture.
Comparison table: CoreAgeRx vs RxActivate
| Criteria | CoreAgeRx | RxActivate |
|---|---|---|
| Price visibility | $79/mo semaglutide; $129/mo tirzepatide published | Price gated behind eligibility questionnaire |
| Membership fee | No Membership Fee (published) | Not disclosed before contact-information gate |
| Intake time | 3-minute online visit (published) | Two-minute eligibility questionnaire |
| Clinician review | Treatment subject to licensed clinician review | Treatment subject to licensed clinician review |
| Medication dose info | Tirzepatide up to 7.5 mg; Semaglutide up to 1.0 mg | Not displayed before eligibility flow completes |
| Regulatory note | Compounded medications, when offered, are not FDA-approved | Compounded medications, when offered, are not FDA-approved |
Patient-facing pros and cons from the captured evidence
CoreAgeRx pros: published flat pricing, no membership fee, dose caps listed. CoreAgeRx cons: the source cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that medication-specific approval status must be confirmed. RxActivate pros: clinician-matched plans and a working eligibility flow with confirmed Alabama serviceability in a synthetic test. RxActivate cons: pricing and billing terms require submission of contact information and are not shown before the gate.
Begin RxActivate eligibility quiz
Final thoughts and recommendation
CoreAgeRx vs RxActivate comes down to whether you prefer upfront published monthly pricing and membership claims or a gated clinician-matching flow that requires contact information before price disclosure. Both state that treatment is available only when a licensed clinician determines it is medically appropriate and both include the same regulatory caution about compounded medications.
Choose CoreAgeRx if you want published flat monthly pricing and explicit semaglutide and tirzepatide dose details up front and prefer to see a claimed monthly price without completing a contact-information gate.
Choose RxActivate if you prefer a clinician-matched plan that uses a two-minute eligibility questionnaire and are prepared to provide contact information before viewing pricing and specific plan terms.